A. , A. Rahnenfuhrer, J. Lengauer, and T. , Improved scoring of functional groups from gene expression data by decorrelating GO graph structure, Bioinformatics, vol.22, pp.1600-1607, 2006.

S. Anders, P. T. Pyl, and W. Huber, HTSeq-a Python framework to work with high-throughput sequencing data, Bioinformatics, vol.31, pp.166-1669, 2015.

M. F. Bear, K. M. Huber, and S. T. Warren, The mGluR theory of fragile X mental retardation, Trends Neurosci, vol.27, pp.370-377, 2004.

A. L. Bhakar, G. Dolen, and M. F. Bear, The pathophysiology of fragile X (and what it teaches us about synapses), Annu. Rev. Neurosci, vol.35, pp.417-443, 2012.

A. Bhattacharya, H. Kaphzan, A. C. Alvarez-dieppa, J. P. Murphy, P. Pierre et al., Genetic removal of p70 S6 kinase 1 corrects molecular, synaptic, and behavioral phenotypes in fragile X syndrome mice, Neuron, vol.76, pp.325-337, 2012.

A. Biever, E. Puighermanal, A. Nishi, A. David, C. Panciatici et al., PKA-dependent phosphorylation of ribosomal protein S6 does not correlate with translation efficiency in striatonigral and striatopallidal medium-sized spiny neurons, J. Neurosci, vol.35, pp.4113-4130, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01883480

T. V. Bilousova, L. Dansie, M. Ngo, J. Aye, J. R. Charles et al., Minocycline promotes dendritic spine maturation and improves behavioural performance in the fragile X mouse model, J. Med. Genet, vol.46, pp.94-102, 2009.

A. Busquets-garcia, M. Gomis-gonzalez, T. Guegan, C. Agustin-pavon, A. Pastor et al., Targeting the endocannabinoid system in the treatment of fragile X syndrome, Nat. Med, vol.19, pp.603-607, 2013.

Z. L. Chen, S. Yoshida, K. Kato, Y. Momota, J. Suzuki et al., Expression and activity-dependent changes of a novel limbic-serine protease gene in the hippocampus, J. Neurosci, vol.15, pp.5088-5097, 1995.

T. A. Comery, J. B. Harris, P. J. Willems, B. A. Oostra, S. A. Irwin et al., Abnormal dendritic spines in fragile X knockout mice: maturation and pruning deficits, Proc. Natl. Acad. Sci. U.S.A, vol.94, pp.5401-5404, 1997.

A. Contractor, V. A. Klyachko, and C. Portera-cailliau, Altered neuronal and circuit excitability in Fragile X Syndrome, Neuron, vol.87, pp.699-715, 2015.

J. C. Darnell, O. Mostovetsky, and R. B. Darnell, FMRP RNA targets: identification and validation, Genes Brain Behav, vol.4, pp.341-349, 2005.

J. C. Darnell, S. J. Van-driesche, C. Zhang, K. Y. Hung, A. Mele et al., FMRP stalls ribosomal translocation on mRNAs linked to synaptic function and autism, Cell, vol.146, pp.247-261, 2011.

B. Davies, I. R. Kearns, J. Ure, C. H. Davies, and R. Lathe, Loss of hippocampal serine protease BSP1/neuropsin predisposes to global seizure activity, J. Neurosci, vol.21, pp.6993-7000, 2001.

G. Dolen, E. Osterweil, B. S. Rao, G. B. Smith, B. D. Auerbach et al., Correction of fragile X syndrome in mice, Neuron, vol.56, pp.955-962, 2007.

C. A. Doll and K. Broadie, Impaired activity-dependent neural circuit assembly and refinement in autism spectrum disorder genetic models, Front. Cell. Neurosci, vol.8, p.30, 2014.

R. C. Gentleman, V. J. Carey, D. M. Bates, B. Bolstad, M. Dettling et al., Bioconductor: open software development for computational biology and bioinformatics, Genome Biol, vol.5, p.80, 2004.

C. G. Gkogkas, A. Khoutorsky, R. Cao, S. M. Jafarnejad, M. Prager-khoutorsky et al., Pharmacogenetic inhibition of eIF4E-dependent Mmp9 mRNA translation reverses fragile X syndrome-like phenotypes, Cell Rep, vol.9, pp.1742-1755, 2014.

C. X. He and C. Portera-cailliau, The trouble with spines in fragile X syndrome: density, maturity and plasticity, Neuroscience, vol.251, pp.120-128, 2013.

M. Heiman, A. Schaefer, S. Gong, J. D. Peterson, M. Day et al., A translational profiling approach for the molecular characterization of CNS cell types, Cell, vol.135, pp.738-748, 2008.

H. Hering and M. Sheng, Dendritic spines: structure, dynamics and regulation, Nat. Rev. Neurosci, vol.2, pp.880-888, 2001.

L. Hou, M. D. Antion, D. Hu, C. M. Spencer, R. Paylor et al., Dynamic translational and proteasomal regulation of fragile X mental retardation protein controls mGluR-dependent long-term depression, Neuron, vol.51, pp.441-454, 2006.

H. Hu, Y. Qin, G. Bochorishvili, Y. Zhu, L. Van-aelst et al., Ras signaling mechanisms underlying impaired GluR1-dependent plasticity associated with fragile X syndrome, J. Neurosci, vol.28, pp.7847-7862, 2008.

K. M. Huber, S. M. Gallagher, S. T. Warren, and M. F. Bear, Altered synaptic plasticity in a mouse model of fragile X mental retardation, Proc. Natl. Acad. Sci. U.S.A, vol.99, pp.7746-7750, 2002.

S. A. Irwin, B. Patel, M. Idupulapati, J. B. Harris, R. A. Crisostomo et al., Abnormal dendritic spine characteristics in the temporal and visual cortices of patients with fragile-X syndrome: a quantitative examination, Am. J. Med. Genet, vol.98, pp.161-167, 2001.

Y. Ishikawa, H. Tamura, and S. Shiosaka, Diversity of neuropsin (KLK8)-dependent synaptic associativity in the hippocampal pyramidal neuron, J. Physiol, vol.589, pp.3559-3573, 2011.

A. Janusz, J. Milek, M. Perycz, L. Pacini, C. Bagni et al., The Fragile X mental retardation protein regulates matrix metalloproteinase 9 mRNA at synapses, J. Neurosci, vol.33, pp.18234-18241, 2013.

R. J. Kelleher, . Iii, and M. F. Bear, The autistic neuron: troubled translation?, Cell, vol.135, pp.401-406, 2008.

P. Kenny and S. Ceman, RNA Secondary structure modulates FMRP's Bi-functional role in the MicroRNA pathway, Int. J. Mol. Sci, vol.17, p.985, 2016.

D. Kim, G. Pertea, C. Trapnell, H. Pimentel, R. Kelley et al., TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions, Genome Biol, vol.14, p.36, 2013.

S. Komai, T. Matsuyama, K. Matsumoto, K. Kato, M. Kobayashi et al., Neuropsin regulates an early phase of schaffer-collateral longterm potentiation in the murine hippocampus, Eur. J. Neurosci, vol.12, pp.1479-1486, 2000.

D. D. Krueger and M. F. Bear, Toward fulfilling the promise of molecular medicine in fragile X syndrome, Annu. Rev. Med, vol.62, pp.411-429, 2011.

B. Langmead and S. L. Salzberg, Fast gapped-read alignment with Bowtie 2, Nat. Methods, vol.9, pp.357-359, 2012.

J. C. Lauterborn, C. S. Rex, E. Kramar, L. Y. Chen, V. Pandyarajan et al., Brain-derived neurotrophic factor rescues synaptic plasticity in a mouse model of fragile X syndrome, J. Neurosci, vol.27, pp.10685-10694, 2007.

M. I. Love, W. Huber, A. , and S. , Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2, Genome Biol, vol.15, p.550, 2014.

R. Lozano, C. A. Rosero, and R. J. Hagerman, Fragile X spectrum disorders, Intractable Rare Dis. Res, vol.3, pp.134-146, 2014.

H. Luuk, S. Koks, M. Plaas, J. Hannibal, J. F. Rehfeld et al., Distribution of Wfs1 protein in the central nervous system of the mouse and its relation to clinical symptoms of the Wolfram syndrome, J. Comp. Neurol, vol.509, pp.642-660, 2008.

L. Madisen, T. A. Zwingman, S. M. Sunkin, S. W. Oh, H. A. Zariwala et al., A robust and high-throughput Cre reporting and characterization system for the whole mouse brain, Nat. Neurosci, vol.13, pp.133-140, 2010.

K. Matsumoto-miyai, A. Ninomiya, H. Yamasaki, H. Tamura, Y. Nakamura et al., NMDA-dependent proteolysis of presynaptic adhesion molecule L1 in the hippocampus by neuropsin, J. Neurosci, vol.23, pp.7727-7736, 2003.

E. L. Mcmillan, A. L. Kamps, S. S. Lake, C. N. Svendsen, and A. Bhattacharyya, Gene expression changes in the MAPK pathway in both Fragile, X., and Down syndrome human neural progenitor cells, Am. J. Stem Cells, vol.1, pp.154-162, 2012.

R. M. Meredith and H. D. Mansvelder, STDP and mental retardation: dysregulation of dendritic excitability in fragile X Syndrome, Front. Synaptic Neurosci, vol.2, p.10, 2010.

R. M. Meredith, C. D. Holmgren, M. Weidum, N. Burnashev, and H. D. Mansvelder, Increased threshold for spike-timing-dependent plasticity is caused by unreliable calcium signaling in mice lacking fragile X gene FMR1, Neuron, vol.54, pp.627-638, 2007.

Y. Momota, S. Yoshida, J. Ito, M. Shibata, K. Kato et al., Blockade of neuropsin, a serine protease, ameliorates kindling epilepsy, Eur. J. Neurosci, vol.10, pp.760-764, 1998.

E. K. Osterweil, S. C. Chuang, A. A. Chubykin, M. Sidorov, R. Bianchi et al., Lovastatin corrects excess protein synthesis and prevents epileptogenesis in a mouse model of fragile X syndrome, Neuron, vol.77, pp.243-250, 2013.

E. K. Osterweil, D. D. Krueger, K. Reinhold, and M. F. Bear, Hypersensitivity to mGluR5 and ERK1/2 leads to excessive protein synthesis in the hippocampus of a mouse model of fragile X syndrome, J. Neurosci, vol.30, pp.15616-15627, 2010.

A. Peters and I. R. Kaiserman-abramof, The small pyramidal neuron of the rat cerebral cortex. The synapses upon dendritic spines, Z Zellforsch Mikrosk Anat, vol.100, pp.487-506, 1969.

M. Pieretti, F. P. Zhang, Y. H. Fu, S. T. Warren, B. A. Oostra et al., Absence of expression of the FMR-1 gene in fragile X syndrome, Cell, vol.66, pp.817-822, 1991.

C. Portera-cailliau and R. Yuste, On the function of dendritic filopodia, Rev. Neurol, vol.33, pp.1158-1166, 2001.

E. Puighermanal, L. Cutando, J. Boubaker-vitre, E. Honore, S. Longueville et al., Anatomical and molecular characterization of dopamine D1 receptor-expressing neurons of the mouse CA1 dorsal hippocampus, Brain Struct. Funct, vol.4, pp.1897-1911, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01936375

M. Qin, T. Huang, M. Kader, L. Krych, Z. Xia et al., R-Baclofen reverses a social behavior deficit and elevated protein synthesis in a mouse model of fragile X Syndrome, Int. J. Neuropsychopharmacol, vol.28, p.18, 2015.

M. Qin, J. Kang, T. V. Burlin, C. Jiang, and C. B. Smith, Postadolescent changes in regional cerebral protein synthesis: an in vivo study in the FMR1 null mouse, J. Neurosci, vol.25, pp.5087-5095, 2005.

B. Radwan, D. Dvorak, and A. A. Fenton, Impaired cognitive discrimination and discoordination of coupled theta-gamma oscillations in Fmr1 knockout mice, Neurobiol. Dis, vol.88, pp.125-138, 2016.

E. Sanz, L. Yang, T. Su, D. R. Morris, G. S. Mcknight et al., Cell-type-specific isolation of ribosome-associated mRNA from complex tissues, Proc. Natl. Acad. Sci. U.S.A, vol.106, pp.13939-13944, 2009.

Z. Shi, K. Fujii, K. M. Kovary, N. R. Genuth, H. L. Rost et al., Heterogeneous ribosomes preferentially translate distinct subpools of mRNAs genome-wide, Mol. Cell, vol.67, pp.71-83, 2017.

H. Sidhu, L. E. Dansie, P. W. Hickmott, D. W. Ethell, and I. M. Ethell, Genetic removal of matrix metalloproteinase 9 rescues the symptoms of fragile X syndrome in a mouse model, J. Neurosci, vol.34, pp.9867-9879, 2014.

R. Tabet, E. Moutin, J. A. Becker, D. Heintz, L. Fouillen et al., Fragile X Mental Retardation Protein (FMRP) controls diacylglycerol kinase activity in neurons, Proc. Natl. Acad. Sci. U.S.A, vol.113, pp.3619-3628, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01594177

H. Tamura, Y. Ishikawa, N. Hino, M. Maeda, S. Yoshida et al., Neuropsin is essential for early processes of memory acquisition and Schaffer collateral long-term potentiation in adult mouse hippocampus in vivo, J. Physiol, vol.570, pp.541-551, 2006.

C. R. Tessier and K. Broadie, The fragile X mental retardation protein developmentally regulates the strength and fidelity of calcium signaling in Drosophila mushroom body neurons, Neurobiol. Dis, vol.41, pp.147-159, 2011.

S. R. Thomson, S. S. Seo, S. A. Barnes, S. R. Louros, M. Muscas et al., Cell-Type-specific translation profiling reveals a novel strategy for treating fragile X Syndrome, Neuron, vol.95, pp.550-563, 2017.

E. Tsilibary, A. Tzinia, L. Radenovic, V. Stamenkovic, T. Lebitko et al., Neural ECM proteases in learning and synaptic plasticity, Prog. Brain Res, vol.214, pp.135-157, 2014.

L. M. Xu, J. R. Li, Y. Huang, M. Zhao, X. Tang et al., AutismKB: an evidence-based knowledgebase of autism genetics, Nucleic Acids Res, vol.40, 2012.